Prevention of Cardiorenal Complications with Sodium–Glucose Cotransporter Type 2 Inhibitors: A Narrative Review

Heart failure (HF) and chronic kidney disease (CKD) are the most frequent first cardiorenal conditions in patients with type 2 diabetes (T2D), which can be exacerbated by other comorbidities, such as hypertension, dyslipidemia, and obesity. To improve their clinical outcomes, patients with T2D need...

Descripción completa

Detalles Bibliográficos
Autores principales: Botana, Manuel, Escalada, Javier, Merchante, Ángel, Reyes, Rebeca, Rozas, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240141/
https://www.ncbi.nlm.nih.gov/pubmed/35704166
http://dx.doi.org/10.1007/s13300-022-01277-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240141/
https://www.ncbi.nlm.nih.gov/pubmed/35704166
http://dx.doi.org/10.1007/s13300-022-01277-1

Ejemplares similares